Suven Life Sciences reports Profit after tax of Rs -109.83 Mln, in the September 2021 quarter

25 Oct 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 11.84 million declined by -86.82% from Rs. 89.80 millions.The Net Loss for the quarter ended September 2021 is Rs. -109.83 millions as compared to Net Loss of Rs. -19.00 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 further decreased to -97.99% as compared to -15.67% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 11.84 89.80 -86.82 31.90 104.09 -69.35 134.78 144.15 -6.50
Other Income 5.03 22.77 -77.91 50.58 48.06 5.24 77.54 140.36 -44.76
PBIDT -97.99 -15.67 525.34 -171.05 -68.52 149.64 -227.93 -212.80 7.11
Interest 1.50 2.53 -40.71 3.03 4.48 -32.37 8.15 4.87 67.35
PBDT -99.49 -18.20 446.65 -174.08 -73.00 138.47 -236.08 -217.67 8.46
Depreciation 10.34 10.75 -3.81 20.68 21.40 -3.36 43.46 41.69 4.25
PBT -109.83 -28.95 279.38 -194.76 -94.40 106.31 -279.54 -259.36 7.78
TAX 0.00 -9.95 0.00 0.00 -34.62 0.00 -53.23 -121.83 -56.31
Deferred Tax 0.00 -9.95 0.00 0.00 -34.62 0.00 -53.23 -141.55 -62.39
PAT -109.83 -19.00 478.05 -194.76 -59.78 225.79 -226.31 -137.53 64.55
Equity 127.28 127.28 0.00 127.28 127.28 0.00 127.28 127.28 0.00
PBIDTM(%) -827.62 -17.45 4642.82 -536.21 -65.83 714.56 -169.11 -147.62 14.56

Suven Life Sciences Share Price

167.80 -3.30 (-1.93%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×